Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20150-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- LGR4 antibody
- Antibody type
- Polyclonal
- Description
- LGR4 antibody (Cat. #20150-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references SOX2 suppresses osteoblast differentiation of MC3T3-E1 cells through activating the transcription of LGR4.
DNA methylation mediated RSPO2 to promote follicular development in mammals.
Silencing of RSPO1 mitigates obesity-related renal fibrosis in mice by deactivating Wnt/β-catenin pathway.
LGR4 overexpression is associated with clinical parameters and poor prognosis of serous ovarian cancer.
Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer.
LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis.
Chen S, Xiao Z, Jiang W
In vitro cellular & developmental biology. Animal 2023 Jan;59(1):1-9
In vitro cellular & developmental biology. Animal 2023 Jan;59(1):1-9
DNA methylation mediated RSPO2 to promote follicular development in mammals.
Zhou X, He Y, Li N, Bai G, Pan X, Zhang Z, Zhang H, Li J, Yuan X
Cell death & disease 2021 Jun 26;12(7):653
Cell death & disease 2021 Jun 26;12(7):653
Silencing of RSPO1 mitigates obesity-related renal fibrosis in mice by deactivating Wnt/β-catenin pathway.
Su X, Zhou G, Tian M, Wu S, Wang Y
Experimental cell research 2021 Aug 15;405(2):112713
Experimental cell research 2021 Aug 15;405(2):112713
LGR4 overexpression is associated with clinical parameters and poor prognosis of serous ovarian cancer.
Zeng Z, Ji N, Yi J, Lv J, Yuan J, Lin Z, Liu L, Feng X
Cancer biomarkers : section A of Disease markers 2020;28(1):65-72
Cancer biomarkers : section A of Disease markers 2020;28(1):65-72
Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer.
Ruan X, Liu A, Zhong M, Wei J, Zhang W, Rong Y, Liu W, Li M, Qing X, Chen G, Li R, Liao Y, Liu Q, Zhang X, Ren D, Wang Y
Molecular therapy oncolytics 2019 Sep 27;14:94-106
Molecular therapy oncolytics 2019 Sep 27;14:94-106
LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis.
Zhu P, Wu J, Wang Y, Zhu X, Lu T, Liu B, He L, Ye B, Wang S, Meng S, Fan D, Wang J, Yang L, Qin X, Du Y, Li C, He L, Ren W, Wu X, Tian Y, Fan Z
Nature cell biology 2018 Oct;20(10):1134-1144
Nature cell biology 2018 Oct;20(10):1134-1144
No comments: Submit comment
No validations: Submit validation data